Aehr Test Systems filings document material events, operating results, capital actions and governance matters for a semiconductor test and burn-in equipment company. Recent Form 8-K disclosures include quarterly financial-result releases covering revenue, bookings, backlog, cash position and GAAP and non-GAAP earnings measures.
The filing record also includes capital-structure disclosures tied to an at-the-market common stock offering under a Form S-3 registration statement, along with proxy and annual meeting materials. Those governance filings address director elections, shareholder voting results, amendments to the company’s equity incentive and employee stock purchase plans, auditor ratification and executive-compensation matters.
Aehr Test Systems entered into an equity distribution agreement on April 8, 2026 with William Blair & Company and Craig-Hallum Capital Group to sell up to $60,000,000 of common stock through an at-the-market offering program. Sales will be made from time to time under an effective Form S-3 shelf registration and an April 8, 2026 prospectus supplement. The agents will use commercially reasonable efforts to place shares and will receive a commission of up to 3.0% of gross proceeds. Either the company or the agents can suspend or terminate the program upon written notice.
Aehr Test Systems is registering an at-the-market offering to sell up to $60,000,000 of its common stock through an Equity Distribution Agreement with William Blair and Craig-Hallum dated April 8, 2026. The offering may be made from time to time at prevailing market prices and the agents will receive commissions up to 3.00%.
The prospectus supplement states the company may use net proceeds for general corporate purposes including working capital, inventory, research and development, commercial activities and capital expenditures. The company reported 30,953,752 shares outstanding as of February 27, 2026 and referenced a last reported sale price of $52.16 per share on April 6, 2026.
Aehr Test Systems reported a sharp downturn for the quarter ended February 27, 2026. Revenue fell to $10.3M from $18.3M, a 44% drop, as wafer-level burn-in systems and contactor shipments declined, especially into electric-vehicle power markets.
Gross margin compressed to 32.7% from 39.2%, and the company posted a quarterly net loss of $3.2M versus a $0.6M loss a year earlier. For the first nine months, revenue declined 31% to $31.2M, with a net loss of $8.5M.
Aehr highlighted growing demand for package-level burn-in systems and boards serving AI-related applications and memory, partially offsetting wafer-level weakness. Cash, cash equivalents and restricted cash were $37.1M as of February 27, 2026, supported by $19.6M of net proceeds from common stock sales under its at-the-market offering program.
Aehr Test Systems reported third quarter fiscal 2026 net revenue of $10.3 million, down from $18.3 million a year earlier, as it posted a GAAP net loss of $3.2 million, or $(0.10) per diluted share. Non-GAAP net loss was $1.5 million, or $(0.05) per diluted share. Despite weaker revenue, Aehr booked $37.2 million of orders with a book-to-bill ratio over 3.5x, lifting backlog to $38.7 million, or $50.9 million including post-quarter bookings. Cash, cash equivalents and restricted cash were $37.1 million, up from $31.0 million in late November 2025. Management expects full-year fiscal 2026 revenue to be on the high side of its $45–$50 million outlook and reiterated second-half guidance of $25–$30 million revenue and non-GAAP net loss per share between $(0.09) and $(0.05), citing strong AI and data center demand.
Aehr Test Systems President and CEO Gayn Erickson filed an amended Form 4 to correct previously reported share counts and ownership form, not to report new trades. The filing confirms a prior tax-withholding disposition of 2,512 shares of Common Stock at $44.32 per share, after which he held 248,787 shares directly. It also clarifies that 2,131 shares at $6.67 per share are held indirectly by a trust, with 293,759 shares beneficially owned through that trust. The footnotes state that earlier Form 4 values for post-transaction holdings and the direct/indirect ownership designation were inaccurate and are now corrected.
AEHR Test Systems Executive VP of R&D Didier Wimmers completed an internal share purchase through the company’s employee stock purchase plan. On April 1, 2026, he acquired 1,873 shares of common stock at $6.6725 per share.
Following this transaction, Wimmers directly holds 16,059 shares of AEHR common stock, which includes shares tied to unvested restricted stock units. The purchase was made under the company’s tax-qualified Employee Stock Purchase Plan, which is treated as a tax-conditioned plan under Internal Revenue Code Section 423 and is exempt from certain short-swing trading liability rules.
Aehr Test Systems VP Alistair N. Sporck reported routine share movements involving compensation and employee purchase activity. On April 2, 298 shares of common stock at $44.32 per share were withheld to satisfy tax obligations upon vesting of restricted stock units, which the company states does not represent a sale. After this, he held 24,855 shares directly, including shares subject to unvested restricted stock units. On April 1, a separate 1,963-share transaction at $6.6725 per share, held indirectly by a trust, reflects shares purchased through the company’s employee stock purchase plan, which is described as a tax-conditioned plan exempt from certain Section 16 short-swing liability, with 7,177 shares held indirectly following that transaction.
AEHR Test Systems CFO Chris Siu reported routine equity-related transactions in company stock. On April 2, 821 shares of common stock at $44.32 per share were withheld to cover tax obligations upon vesting of restricted stock units, which the company notes is not a market sale. On April 1, 2,095 shares at $6.6725 per share were acquired through the company’s Employee Stock Purchase Plan and are held indirectly in a trust. Following these transactions, Siu holds 71,437 shares directly and 7,306 shares indirectly, with the indirect amount including shares subject to unvested restricted stock units.
AEHR TEST SYSTEMS executive Alberto Salamone reported routine equity compensation-related transactions. On April 2, 2026, 553 shares of common stock were withheld at $44.32 per share to cover tax obligations upon vesting of restricted stock units, which the disclosure states does not represent a sale by Salamone. On April 1, 2026, 1,672 shares of common stock were purchased through the company’s Amended and Restated 2006 Employee Stock Purchase Plan, described as a tax-conditioned plan under Internal Revenue Code Section 423. Following these transactions, Salamone directly held 78,025 shares of AEHR common stock, and this amount includes shares subject to unvested restricted stock units.
Aehr Test Systems executive Vernon Rogers reported routine equity compensation activity. On April 1, he acquired 1,558 shares of common stock at $6.6725 per share through the company’s Amended and Restated 2006 Employee Stock Purchase Plan, described as a tax-conditioned plan under Section 423 of the Internal Revenue Code and exempt from Section 16 short-swing rules.
On April 2, 336 shares of common stock valued at $44.32 per share were withheld to cover tax obligations when restricted stock units vested, which the disclosure clarifies is not a sale by Rogers. After these transactions, he directly holds 178,428 shares, and the reported amount includes shares underlying unvested restricted stock units.